SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Acquisition

30 Jul 2007 07:01

Rentokil Initial PLC30 July 2007 30 July 2007 Rentokil Initial to acquire major regional US pest control company Rentokil Initial plc (LSE: RTO) announces that it has entered into an agreementfor the acquisition of the business and assets of Presto-X-Company from itsprivate owners for an initial cash consideration of US$38 million (£19 million)plus further cash consideration of up to $7 million (£3.5 million) based on theactual results for the year to 31 December 2007. Presto-X is a significantregional pest control company based in Omaha, Nebraska, USA, focusedpredominantly on commercial customers. Its turnover for the 12 months to 31December 2006 was US$29 million. Presto-X has 300 employees and operates from 21 branches within the centralstates of the USA including Denver, Dallas, Memphis, St Louis, Kansas City,Chicago and Oklahoma City. It is an excellent operational fit with Rentokil'sexisting North American operations, which operate from 56 branches, primarilyacross the eastern US states. Both organisations are shareholders in Copesan,an alliance of companies created to provide pest management solutions tocustomers with locations across North America. Doug Flynn, Chief Executive of Rentokil Initial, said: "Today's announcement is fully in line with our strategy in North America ofacquiring quality regional companies which expand our footprint, build densityin core regions and improve returns in this growing market. This follows thesuccessful acquisition and integration of JC Ehrlich, America's fourth largestpest control company, in 2006. Our business in North America continues tostrengthen its position in the world's largest pest control market." Ends Notes to Editors Rentokil Initial is one of the largest business services companies in the world,operating in all the major economies of Europe, North America, Asia Pacific andAfrica. The company provides a wide range of support services in over 40countries where the 'Rentokil' and 'Initial' brands represent innovation, deepexpertise and consistent quality of service. Services include textiles andwashroom services, pest control, office plants and artwork, parcels delivery andfacilities services. Rentokil operates pest control services in 38 countries, covering every majoreconomic centre around the world. In 2006, Rentokil Pest Control revenues were£280 million, up 33.7%, of which the USA accounted for 28%. Presto-X management has been at the forefront of the pest control industry inthe USA. Co-owner Ward Combs was previously President of the National PestManagement Association, while Co-owner Jerry Keown was long-time Chairman of theGovernment Affairs Committee of NPMA and was recently honoured for his servicein that capacity. For further information, please contact Rentokil Initial plc Malcolm Padley, Corporate Communications - 020 7866 3027/ 07788 978 199 Lisa Williams, Investor Relations - 020 7866 3028/07980 895 419 Brunswick Group Kate Holgate - 020 7404 5959/07974 982402 Tom Williams - 020 7404 5959/07834 502 361 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
25th Nov 20193:25 pmRNSHolding(s) in Company
14th Nov 20194:00 pmRNSHolding(s) in Company
8th Nov 20195:30 pmRNSHolding(s) in Company
8th Nov 20199:40 amRNSDirector/PDMR Shareholding
6th Nov 20195:00 pmRNSHolding(s) in Company
5th Nov 20195:10 pmRNSHolding(s) in Company
1st Nov 20197:00 amRNSAcquisition of Florida Pest Control, USA
31st Oct 20194:30 pmRNSDirector/PDMR Shareholding
17th Oct 20197:00 amRNS3rd Quarter Trading Update
30th Sep 201910:20 amRNSBlock listing Interim Review
23rd Sep 201910:30 amRNSHolding(s) in Company
13th Sep 20194:00 pmRNSDirector/PDMR Shareholding
19th Aug 20193:15 pmRNSDirector/PDMR Shareholding
5th Aug 20191:58 pmRNSDirector/PDMR Shareholding
31st Jul 20197:00 amRNSInterim Results
23rd Jul 20197:00 amRNSAppointment of Joint Corporate Broker
2nd Jul 201910:35 amRNSPost Stabilisation Notice
21st Jun 20197:00 amRNSDirectorate Change
11th Jun 201912:00 pmRNSHolding(s) in Company
31st May 20195:00 pmRNSHolding(s) in Company
30th May 20195:00 pmRNSDirector Declaration
17th May 20194:04 pmRNSDirector/PDMR Shareholding
15th May 20199:30 amRNSPre Stabilisation Notice
8th May 20192:30 pmRNSResult of AGM
29th Apr 201911:40 amRNSDirector/PDMR Shareholding
18th Apr 20197:00 amRNSQ1 Trading Update
12th Apr 20196:25 pmRNSDirector/PDMR Shareholding - Replacement
11th Apr 20194:37 pmRNSDirector/PDMR Shareholding
10th Apr 20191:57 pmRNSDirector Declaration
1st Apr 20197:00 amRNSBlock listing Interim Review
29th Mar 20197:00 amRNSTotal Voting Rights
27th Mar 201911:18 amRNSAnnual Financial Report
25th Mar 20199:58 amRNSDirector/PDMR Shareholding
12th Mar 201912:17 pmRNSDirector/PDMR Shareholding
6th Mar 20192:00 pmRNSAdditional Listing
6th Mar 20191:05 pmRNSDirector/PDMR Shareholding
1st Mar 20197:00 amRNSInnovative good causes initiative
28th Feb 20195:15 pmRNSDirector/PDMR Shareholding
28th Feb 20197:05 amRNSDirectorate Changes and Appointment of Chairman
28th Feb 20197:00 amRNSFinal Results
15th Feb 20195:15 pmRNSHolding(s) in Company
1st Feb 20197:00 amRNSChange to Director's details
4th Dec 20187:00 amRNSDefined benefit pension scheme buy-in with PIC
20th Nov 20185:17 pmRNSHolding(s) in Company
16th Nov 20184:14 pmRNSHolding(s) in Company
24th Oct 20182:36 pmRNSDirector/PDMR Shareholding
18th Oct 20187:00 amRNSQ3 Trading Update
2nd Oct 201812:17 pmRNSBlock listing Interim Review
25th Sep 20187:25 amRNSDirector Declaration
13th Sep 20184:43 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.